Role of nanocarriers for inflammation treatment

Akshansh Sharma; Ishan Sharma; Ankit; Sachin Kumar Singh; Kamal Dua; Sadanand Pandey; Deepak Kumar

doi:10.1016/B978-0-323-95325-2.00012-2

Role of nanocarriers for inflammation treatment

Akshansh Sharma
, Ishan Sharma
, Ankit
, Sachin Kumar Singh
, Kamal Dua
, Sadanand Pandey
, Deepak Kumar

Shoolini University of Biotechnology and Management Sciences
Lovely Professional University
University of Technology Sydney
Yeungnam University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

4 Scopus citations

Abstract

Nanotechnology plays a vital role in medication delivery, and different types of nanoparticles (NPs) have shown unique features that might lead to new therapeutic treatment options. Anti-inflammatory medicines have exploited NP-mediated drug delivery methods. Inflammation’s pathophysiology has a large influence on disorder like as bone, skin, and internal. Anti-inflammatory medication distribution that is efficient can minimize medical dose while also improving therapeutic impact. In this chapter, we examine NPs with possible anti-inflammatory efficacy, as well as a future outlook on nanomedicine’s applicability in inflammatory illnesses.

Original language	English
Title of host publication	Nanotechnology for Drug Delivery and Pharmaceuticals
Publisher	Elsevier
Pages	111-129
Number of pages	19
ISBN (Electronic)	9780323953252
ISBN (Print)	9780323953269
DOIs	https://doi.org/10.1016/B978-0-323-95325-2.00012-2
State	Published - 1 Jan 2023
Externally published	Yes

Keywords

Nanotechnology
drug delivery
inflammatory diseases
nanoparticles

Access to Document

10.1016/B978-0-323-95325-2.00012-2

Cite this

@inbook{202909bac4a642ed93348374130a80ec,

title = "Role of nanocarriers for inflammation treatment",

abstract = "Nanotechnology plays a vital role in medication delivery, and different types of nanoparticles (NPs) have shown unique features that might lead to new therapeutic treatment options. Anti-inflammatory medicines have exploited NP-mediated drug delivery methods. Inflammation{\textquoteright}s pathophysiology has a large influence on disorder like as bone, skin, and internal. Anti-inflammatory medication distribution that is efficient can minimize medical dose while also improving therapeutic impact. In this chapter, we examine NPs with possible anti-inflammatory efficacy, as well as a future outlook on nanomedicine{\textquoteright}s applicability in inflammatory illnesses.",

keywords = "Nanotechnology, drug delivery, inflammatory diseases, nanoparticles",

author = "Akshansh Sharma and Ishan Sharma and Ankit and Singh, \{Sachin Kumar\} and Kamal Dua and Sadanand Pandey and Deepak Kumar",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-95325-2.00012-2",

language = "English",

isbn = "9780323953269",

pages = "111--129",

booktitle = "Nanotechnology for Drug Delivery and Pharmaceuticals",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Role of nanocarriers for inflammation treatment

AU - Sharma, Akshansh

AU - Sharma, Ishan

AU - Ankit,

AU - Singh, Sachin Kumar

AU - Dua, Kamal

AU - Pandey, Sadanand

AU - Kumar, Deepak

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Nanotechnology plays a vital role in medication delivery, and different types of nanoparticles (NPs) have shown unique features that might lead to new therapeutic treatment options. Anti-inflammatory medicines have exploited NP-mediated drug delivery methods. Inflammation’s pathophysiology has a large influence on disorder like as bone, skin, and internal. Anti-inflammatory medication distribution that is efficient can minimize medical dose while also improving therapeutic impact. In this chapter, we examine NPs with possible anti-inflammatory efficacy, as well as a future outlook on nanomedicine’s applicability in inflammatory illnesses.

AB - Nanotechnology plays a vital role in medication delivery, and different types of nanoparticles (NPs) have shown unique features that might lead to new therapeutic treatment options. Anti-inflammatory medicines have exploited NP-mediated drug delivery methods. Inflammation’s pathophysiology has a large influence on disorder like as bone, skin, and internal. Anti-inflammatory medication distribution that is efficient can minimize medical dose while also improving therapeutic impact. In this chapter, we examine NPs with possible anti-inflammatory efficacy, as well as a future outlook on nanomedicine’s applicability in inflammatory illnesses.

KW - Nanotechnology

KW - drug delivery

KW - inflammatory diseases

KW - nanoparticles

UR - https://www.scopus.com/pages/publications/85150097126

U2 - 10.1016/B978-0-323-95325-2.00012-2

DO - 10.1016/B978-0-323-95325-2.00012-2

M3 - Chapter

AN - SCOPUS:85150097126

SN - 9780323953269

SP - 111

EP - 129

BT - Nanotechnology for Drug Delivery and Pharmaceuticals

PB - Elsevier

ER -

Role of nanocarriers for inflammation treatment

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this